{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:19:38Z","timestamp":1771319978301,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Education Department of Anhui Province","award":["293621"],"award-info":[{"award-number":["293621"]}]},{"name":"Natural Science Foundation of Education Department of Anhui Province","award":["2022AH040160"],"award-info":[{"award-number":["2022AH040160"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370608"],"award-info":[{"award-number":["82370608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2208085MH204"],"award-info":[{"award-number":["2208085MH204"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anhui Provincial Special Fund for Clinical Medical Research Transformation","award":["202304295107020040"],"award-info":[{"award-number":["202304295107020040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37404-2","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:39:24Z","timestamp":1769668764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of CD38+CD8+ T cells in hepatitis B-related acute-on-chronic liver failure and its prognostic value"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiali","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shucheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"37404_CR1","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","volume":"382","author":"V Arroyo","year":"2020","unstructured":"Arroyo, V., Moreau, R. & Jalan, R. Acute-on-chronic liver failure. N Engl. J. Med. 382, 2137\u20132145. https:\/\/doi.org\/10.1056\/NEJMra1914900 (2020).","journal-title":"N Engl. J. Med."},{"key":"37404_CR2","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.14309\/ajg.0000000000000771","volume":"115","author":"Z Cao","year":"2020","unstructured":"Cao, Z. et al. The use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis. Off J. Am. Coll. Gastroenterol. Acg. 115, 2026. https:\/\/doi.org\/10.14309\/ajg.0000000000000771 (2020).","journal-title":"Off J. Am. Coll. Gastroenterol. Acg"},{"key":"37404_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cgh.2022.03.016","volume":"21","author":"J Luo","year":"2023","unstructured":"Luo, J. et al. Predicting the onset of hepatitis B Virus-Related Acute-on-Chronic liver failure. Clin. Gastroenterol. Hepatol. Off Clin. Pract. J. Am. Gastroenterol. Assoc. 21, 681\u2013693. https:\/\/doi.org\/10.1016\/j.cgh.2022.03.016 (2023).","journal-title":"Clin. Gastroenterol. Hepatol. Off Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"37404_CR4","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41467-024-46047-8","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4\u2009+\u2009T-cell exhaustion. Nat. Commun. 15, 1835. https:\/\/doi.org\/10.1038\/s41467-024-46047-8 (2024).","journal-title":"Nat. Commun."},{"key":"37404_CR5","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3389\/fimmu.2020.02013","volume":"11","author":"A Khanam","year":"2020","unstructured":"Khanam, A. & Kottilil, S. Abnormal innate immunity in acute-on-chronic liver failure: immunotargets for therapeutics. Front. Immunol. 11, 2013. https:\/\/doi.org\/10.3389\/fimmu.2020.02013 (2020).","journal-title":"Front. Immunol."},{"key":"37404_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/a-2464-9543","author":"D Hudson","year":"2024","unstructured":"Hudson, D. et al. Advancements in MELD score and its impact on hepatology. Semin Liver Dis. https:\/\/doi.org\/10.1055\/a-2464-9543 (2024).","journal-title":"Semin Liver Dis."},{"key":"37404_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin, S. K. et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol. Int. 13, 353\u2013390. https:\/\/doi.org\/10.1007\/s12072-019-09946-3 (2019).","journal-title":"Hepatol. Int."},{"key":"37404_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan, R. et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J. Hepatol. 61, 1038\u20131047. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.012 (2014).","journal-title":"J. Hepatol."},{"key":"37404_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","volume":"75","author":"J Li","year":"2021","unstructured":"Li, J. et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J. Hepatol. 75, 1104\u20131115. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.026 (2021).","journal-title":"J. Hepatol."},{"key":"37404_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 Blockade. Cancer Discov. 8, 1156\u20131175. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1033 (2018).","journal-title":"Cancer Discov"},{"key":"37404_CR11","doi-asserted-by":"publisher","first-page":"eabe8195","DOI":"10.1126\/scitranslmed.abe8195","volume":"14","author":"E Wennerberg","year":"2022","unstructured":"Wennerberg, E. et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Sci. Transl Med. 14, eabe8195. https:\/\/doi.org\/10.1126\/scitranslmed.abe8195 (2022).","journal-title":"Sci. Transl Med."},{"key":"37404_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41419-021-03968-2","volume":"12","author":"L Gao","year":"2021","unstructured":"Gao, L. et al. The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression. Cell. Death Dis. 12, 680. https:\/\/doi.org\/10.1038\/s41419-021-03968-2 (2021).","journal-title":"Cell. Death Dis."},{"key":"37404_CR13","doi-asserted-by":"publisher","first-page":"19831","DOI":"10.1074\/jbc.REV119.009635","volume":"294","author":"HC Lee","year":"2019","unstructured":"Lee, H. C. & Zhao, Y. J. Resolving the topological enigma in Ca2\u2009+\u2009signaling by Cyclic ADP-ribose and NAADP. J. Biol. Chem. 294, 19831\u201319843. https:\/\/doi.org\/10.1074\/jbc.REV119.009635 (2019).","journal-title":"J. Biol. Chem."},{"key":"37404_CR14","doi-asserted-by":"publisher","unstructured":"Fliegert, R., Riekehr, W. M. & Guse, A. H. Does Cyclic ADP-ribose (cADPR) activate the non-selective cation channel TRPM2? Front Immunol. 11, 2018. https:\/\/doi.org\/10.3389\/fimmu.2020.02018  (2020).","DOI":"10.3389\/fimmu.2020.02018"},{"key":"37404_CR15","doi-asserted-by":"publisher","first-page":"6630295","DOI":"10.1155\/2021\/6630295","volume":"2021","author":"S Dwivedi","year":"2021","unstructured":"Dwivedi, S. et al. CD38 and regulation of the immune response cells in cancer. J. Oncol. 2021, 6630295. https:\/\/doi.org\/10.1155\/2021\/6630295 (2021).","journal-title":"J. Oncol."},{"key":"37404_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","volume":"8","author":"SK Sarin","year":"2014","unstructured":"Sarin, S. K. et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL) 2014. Hepatol. Int. 8, 453\u2013471. https:\/\/doi.org\/10.1007\/s12072-014-9580-2 (2014).","journal-title":"Hepatol. Int."},{"key":"37404_CR17","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1016\/S2352-3026(19)30249-2","volume":"7","author":"MS Raab","year":"2020","unstructured":"Raab, M. S. et al. MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial. Lancet Haematol. 7, e381\u2013e394. https:\/\/doi.org\/10.1016\/S2352-3026(19)30249-2 (2020).","journal-title":"Lancet Haematol."},{"key":"37404_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41590-019-0441-y","volume":"20","author":"V Verma","year":"2019","unstructured":"Verma, V. et al. PD-1 Blockade in subprimed CD8 cells induces dysfunctional PD-1\u2009+\u2009CD38hi cells and anti-PD-1 resistance. Nat. Immunol. 20, 1231\u20131243. https:\/\/doi.org\/10.1038\/s41590-019-0441-y (2019).","journal-title":"Nat. Immunol."},{"key":"37404_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41419-022-05383-7","volume":"13","author":"Y Ma","year":"2022","unstructured":"Ma, Y. et al. Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibility. Cell. Death Dis. 13, 944. https:\/\/doi.org\/10.1038\/s41419-022-05383-7 (2022).","journal-title":"Cell. Death Dis."},{"key":"37404_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40246-019-0251-1","volume":"13","author":"MA Assiri","year":"2019","unstructured":"Assiri, M. A. et al. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. Hum. Genomics. 13, 65. https:\/\/doi.org\/10.1186\/s40246-019-0251-1 (2019).","journal-title":"Hum. Genomics"},{"key":"37404_CR21","doi-asserted-by":"publisher","first-page":"101388","DOI":"10.1016\/j.jbc.2021.101388","volume":"297","author":"M Dall","year":"2021","unstructured":"Dall, M. et al. Hepatocyte-specific perturbation of NAD\u2009+\u2009biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. J. Biol. Chem. 297, 101388. https:\/\/doi.org\/10.1016\/j.jbc.2021.101388 (2021).","journal-title":"J. Biol. Chem."},{"key":"37404_CR22","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","volume":"67","author":"J Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez, J. et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut 67, 1870\u20131880. https:\/\/doi.org\/10.1136\/gutjnl-2017-314240 (2018).","journal-title":"Gut"},{"key":"37404_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhep.2023.02.035","volume":"79","author":"I Montali","year":"2023","unstructured":"Montali, I. et al. Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B. J. Hepatol. 79, 50\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.035 (2023).","journal-title":"J. Hepatol."},{"key":"37404_CR24","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s12072-022-10386-9","volume":"16","author":"H-J Li","year":"2022","unstructured":"Li, H-J. et al. Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol. Int. 16, 1398\u20131411. https:\/\/doi.org\/10.1007\/s12072-022-10386-9 (2022).","journal-title":"Hepatol. Int."},{"key":"37404_CR25","doi-asserted-by":"publisher","first-page":"762296","DOI":"10.3389\/fmed.2021.762296","volume":"8","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. CD200R combined neutrophil-lymphocyte ratio predict 90-day mortality in HBV-related acute-on-chronic liver failure. Front. Med. 8, 762296. https:\/\/doi.org\/10.3389\/fmed.2021.762296 (2021).","journal-title":"Front. Med."},{"key":"37404_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41420-020-00299-7","volume":"6","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. sTim-3 alleviates liver injury via regulation of the immunity microenvironment and autophagy. Cell. Death Discov. 6, 62. https:\/\/doi.org\/10.1038\/s41420-020-00299-7 (2020).","journal-title":"Cell. Death Discov"},{"key":"37404_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12967-023-04294-1","volume":"21","author":"B Peng","year":"2023","unstructured":"Peng, B. et al. Intrahepatic macrophage reprogramming associated with lipid metabolism in hepatitis B virus-related acute-on-chronic liver failure. J. Transl Med. 21, 419. https:\/\/doi.org\/10.1186\/s12967-023-04294-1 (2023).","journal-title":"J. Transl Med."},{"key":"37404_CR28","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3389\/fimmu.2018.02948","volume":"9","author":"E Triantafyllou","year":"2018","unstructured":"Triantafyllou, E. et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front. Immunol. 9, 2948. https:\/\/doi.org\/10.3389\/fimmu.2018.02948 (2018).","journal-title":"Front. Immunol."},{"key":"37404_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12072-013-9485-5","volume":"8","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model. Hepatol. Int. 8, 64\u201371. https:\/\/doi.org\/10.1007\/s12072-013-9485-5 (2014).","journal-title":"Hepatol. Int."},{"key":"37404_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1749-6632.2012.06680.x","volume":"1270","author":"C Tuthill","year":"2012","unstructured":"Tuthill, C. et al. Thymosin \u03b11 continues to show promise as an enhancer for vaccine response. Ann. N. Y. Acad. Sci. 1270, 21\u201327. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06680.x (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"37404_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cld.2018.01.014","volume":"22","author":"R Olivo","year":"2018","unstructured":"Olivo, R., Guarrera, J. V. & Pyrsopoulos, N. T. Liver transplantation for acute liver failure. Clin. Liver Dis. 22, 409\u2013417. https:\/\/doi.org\/10.1016\/j.cld.2018.01.014 (2018).","journal-title":"Clin. Liver Dis."},{"key":"37404_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.hbpd.2019.07.003","volume":"18","author":"P Chen","year":"2019","unstructured":"Chen, P. et al. The immunological roles in acute-on-chronic liver failure: an update. Hepatobiliary Pancreat. Dis. Int. 18, 403\u2013411. https:\/\/doi.org\/10.1016\/j.hbpd.2019.07.003 (2019).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"37404_CR33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","volume":"10","author":"R Martin-Mateos","year":"2019","unstructured":"Martin-Mateos, R., Alvarez-Mon, M. & Albillos, A. Dysfunctional immune response in acute-on-chronic liver failure: it takes two to Tango. Front. Immunol. 10, 973. https:\/\/doi.org\/10.3389\/fimmu.2019.00973 (2019).","journal-title":"Front. Immunol."},{"key":"37404_CR34","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI130197","volume":"130","author":"D Wu","year":"2020","unstructured":"Wu, D. et al. Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure. J. Clin. Invest. 130, 2069\u20132080. https:\/\/doi.org\/10.1172\/JCI130197 (2020).","journal-title":"J. Clin. Invest."},{"key":"37404_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2147\/IDR.S437926","volume":"17","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure. Infect. Drug Resist. 17, 1185\u20131198. https:\/\/doi.org\/10.2147\/IDR.S437926 (2024).","journal-title":"Infect. Drug Resist."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37404-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37404-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37404-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:45:56Z","timestamp":1771317956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37404-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37404"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37404-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the 1975 Declaration of Helsinki and was approved by the Medical Ethics Committee of the First Affiliated Hospital of Anhui Medical University (Approval No. 2025230). Written informed consent was obtained from all patients or their legal representatives prior to participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"6609"}}